Results 161 to 170 of about 130,584 (225)

Suppression of premature ventricular complexes with the PDE5 inhibitor sildenafil: First clinical experience

open access: yesExperimental Physiology, Volume 111, Issue 3, Page 625-631, 1 March 2026.
Abstract The phosphodiesterase‐5 inhibitor sildenafil suppresses ventricular arrhythmias in a sheep model of drug‐induced long QT. In that study, ventricular arrhythmias were abolished by reducing premature ventricular complexes (PVCs) and delaying PVC onset, thus preventing ‘R‐on‐T’ ventricular tachycardia.
David C. Hutchings   +3 more
wiley   +1 more source

Drug Repositioning in Doxorubicin-Induced Cardiotoxicity Protection. [PDF]

open access: yesInt J Mol Sci
Kosić M   +3 more
europepmc   +1 more source

Neurotransmitters and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets. [PDF]

open access: yesMedComm (2020)
Li G   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Inhibition of the adrenergic phenotype in cultured neural crest cells by norepinephrine uptake inhibitors

Developmental Biology, 1989
Tricyclic antidepressants in combination with in vitro clonal analysis of quail neural crest cells were used to examine the role the norepinephrine uptake mechanism might play in the development of adrenergic neural crest derivatives. Norepinephrine (NE) uptake inhibitors blocked expression of the adrenergic phenotype by neural crest cells.
Maya Sieber-Blum
openaire   +3 more sources

Home - About - Disclaimer - Privacy